Transcriptome profiling of the cancer and normal tissues from gastric cancer patients by deep sequencing
Gastric cancer is the second highest cause of global cancer mortality. Genome-wide screening of transcriptome dysregulation between cancer and normal tissues would provide insights into the molecular basis of gastric cancer initiation and progression. Recently, next-generation sequencing technique has started to revolutionize biomedical studies. RNA-seq method has become a superior approach in cancer studies, which enables accurate measurement of gene expression levels. In this work, we used RNA-seq data from tumor and matched normal samples to investigate their transcriptional changes. We totally identified 114 significantly differentially expressed genes, and these genes are highly enriched in some gene ontology (GO) categories, such as “digestive system process,” “regulation of body fluid levels,” “secretion,” “digestion,” etc. This study provided the preliminary survey of the transcriptome of Chinese gastric cancer patients, which provides better insights into the complexity of regulatory changes during tumorgenesis.
KeywordsGastric cancer RNA-seq method Mortality
- 4.Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687–97.PubMedCrossRefGoogle Scholar
- 13.Langmead B. Aligning short sequencing reads with Bowtie. Current protocols in bioinformatics / editoral board, Andreas D. Baxevanis … [et al.], Chapter 11, Unit 11 17; 2010.Google Scholar
- 15.Ferreira JA. The Benjamini-Hochberg method in the case of discrete test statistics. Int J Biostat. 2007;3(Article 11).Google Scholar